Eligibility criteria
Condition
Rheumatoid Arthritis
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
Patients with RA on stable therapy defined as:
Etanercept: 1x50 mg/week or 2x25mg/week for at least 1 consecutive year. Adalimumab: 1x40
mg every other week for at least 1 consecutive year. Oral corticosteroids: stable doses for
≥ 12 weeks before baseline Methotrexate: stable doses for ≥ 12 weeks before baseline Other
DMARD's: stable doses for ≥ 12 weeks before baseline
Exclusion criteria
Show details
Participation in other clinical or observational trials.